Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 0.51 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 3/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.41 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.41 |
| ▸ | VNN1 | O95497 | 2/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14418830 | 0.92 | GSK3B (0.51) | GSK3BCHEK1MEN1KMT2ACDK2 | |
| SCHEMBL13119216 | 0.92 | GSK3B (0.64) | GSK3BCDK2CCNE1 | |
| SCHEMBL14418651 | 0.86 | GSK3B (0.55) | GSK3BCHEK1CDK2CCNE1CCNA2 | |
| SCHEMBL14545947 | 0.86 | GSK3B (0.56) | GSK3BCHEK1CDK2CCNE1VNN1 | |
| SCHEMBL14607246 | 0.85 | GSK3B (0.53) | GSK3BCHEK1CDK2CCNE1MAP3K12 | |
| SCHEMBL14581362 | 0.85 | GSK3B (0.50) | GSK3BCHEK1CDK2CCNE1MAP3K12 | |
| SCHEMBL14545949 | 0.84 | GSK3B (0.60) | GSK3BCHEK1CDK2CCNE1VNN1 | |
| SCHEMBL14545872 | 0.84 | GSK3B (0.53) | GSK3BCHEK1CDK2CCNE1MAP3K12 | |
| SCHEMBL14418650 | 0.84 | GSK3B (0.61) | GSK3BCHEK1CDK2CCNE1VNN1 | |
| SCHEMBL14545952 | 0.84 | GSK3B (0.52) | GSK3BCHEK1MEN1KMT2ACDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1720882-B1 | PYRAZOLOPYRIMIDINE-DERIVATIVES AS CYCLIN DEPENDENT KINASE INHIBITORS | SCHERING CORP (US) | 2011-01-05 | — | — | EP | disclosed |